Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novanta | NOVT | Oct 31, 2024 | 170.24 | -1.96 |
Novartis ADR | NVS | Oct 31, 2024 | 108.40 | -1.37 |
Novavax | NVAX | Oct 31, 2024 | 9.61 | -2.34 |
Novo Integrated Sciences | NVOS | Oct 31, 2024 | 0.18 | -3.00 |
Novo Nordisk ADR | NVO | Oct 31, 2024 | 111.95 | -1.14 |
NovoCure | NVCR | Oct 31, 2024 | 15.18 | -10.65 |
Novonix ADR | NVX | Oct 31, 2024 | 1.84 | -1.87 |
NRG Energy | NRG | Oct 31, 2024 | 90.40 | +2.20 |
NRx Pharmaceuticals | NRXP | Oct 31, 2024 | 1.37 | -4.20 |
NSTS Bancorp | NSTS | Oct 31, 2024 | 11.19 | +1.54 |
Nu Holdings | NU | Oct 31, 2024 | 15.09 | -4.07 |
Nu Skin Enterprises | NUS | Oct 31, 2024 | 6.19 | -0.96 |
Nuburu | BURU | Oct 31, 2024 | 0.45 | -5.36 |
NuCana ADR | NCNA | Oct 31, 2024 | 1.62 | -6.36 |
Nucor | NUE | Oct 31, 2024 | 141.84 | -0.60 |
Nukkleus | NUKK | Oct 31, 2024 | 2.22 | -9.67 |
Nurix Therapeutics | NRIX | Oct 31, 2024 | 24.58 | +2.12 |
NuScale Power | SMR | Oct 31, 2024 | 19.14 | -7.98 |
Nustar Energy C Pref | NS-C | Oct 31, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Oct 31, 2024 | 62.10 | -3.15 |
Nutex Health | NUTX | Oct 31, 2024 | 22.29 | -5.31 |
Nutriband | NTRB | Oct 31, 2024 | 6.19 | +0.32 |
Nutrien | NTR | Oct 31, 2024 | 47.68 | -0.58 |
Nuvalent A | NUVL | Oct 31, 2024 | 88.49 | -1.94 |
Nuvation Bio A | NUVB | Oct 31, 2024 | 2.21 | -5.56 |
Nuvectis Pharma | NVCT | Oct 31, 2024 | 7.47 | -5.32 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Oct 31, 2024 | 12.79 | +1.19 |
Nuveen Amtfree Municipal Value Fund | NUW | Oct 31, 2024 | 13.89 | +0.65 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Oct 31, 2024 | 11.60 | +0.52 |
Nuveen Arizona Quality Municipal Fund | NAZ | Oct 31, 2024 | 11.60 | +0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.